Trial Profile
Randomized Controlled Study to Evaluate the Safety and Efficacy of SFPP in Knee Osteoarthritis Using Diclofenac Gel as the Comparator
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 23 Aug 2021
Price :
$35
*
At a glance
- Drugs Esflurbiprofen (Primary) ; Diclofenac
- Indications Pain
- Focus Registrational; Therapeutic Use
- Sponsors Taisho Pharmaceutical
- 18 Aug 2021 Status changed from recruiting to completed.
- 13 Jul 2020 Planned End Date changed from 31 Oct 2020 to 31 May 2021.
- 13 Jul 2020 Planned primary completion date changed from 31 Aug 2020 to 31 Mar 2021.